v3.23.3
Nature of Business - Additional Information (Details)
$ in Millions
9 Months Ended
Oct. 15, 2023
USD ($)
Sep. 30, 2023
Segment
Product
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Operating segments (in segments) | Segment   1
FDA approved products (in products) | Product   0
Subsequent Event | Gilead Sciences, Inc. | Option, License and Collaboration Agreement    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Proceeds received in collaboration agreement | $ $ 100.0